RXI PHARMACEUTICALS CORP Chart calendar RXi Pharmaceuticals Corp
79d15ce8d79df127f3d44dec06.Ofs97dL6yz6yqKkaBDMBxL0FW5RmwZnuHmwVsqtTlcM.e71pnLq1rw_U755VYwRDm41AI8MSg-7DWiFf0cdq0Il3lFO6ucKNWf7t_A~b154b03fe3d2504ce2043a98be66def5
Upcoming events on RXi Pharmaceuticals Corp
Past events on RXi Pharmaceuticals Corp
| 02/04/2024 05:00 pm | Q4 2023 Earnings Release |
| 22/03/2024 10:30 pm | Immunotherapy of Cancer Conference |
| 21/03/2024 10:30 pm | Immunotherapy of Cancer Conference |
| 21/03/2024 10:30 pm | Immunotherapy of Cancer Conference - Poster No : P01.03 |
| 10/11/2023 03:00 am | Q3 2023 Earnings Release |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 474 |
| 14/10/2023 10:00 pm | AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e |
| 14/10/2023 10:00 pm | AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4 |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 11/08/2023 02:00 am | Q2 2023 Earnings Release |
| 20/07/2023 06:30 pm | Annual General Meeting |
| 18/05/2023 12:30 am | American Society of Gene & Cell Therapy Meeting - Abstract No: 544 |
| 12/05/2023 02:30 am | Q1 2023 Earnings Release |
| 18/04/2023 11:00 pm | American Association for Cancer Research Meeting |
| 17/04/2023 06:30 pm | American Association for Cancer Research Meeting - Intratumoral PH-762 |
| 23/03/2023 02:35 am | Q4 2022 Earnings Release |
| 26/01/2023 | Reverse Split: 1 of 12 |
| 08/01/2023 | Dermatology Summit |
| 11/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract #: 1402 |
| 11/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract #:788 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,99 -8,60 -4.5% | -8,79 -8,80 0.08% | -13,5 -14,4 6.17% | -11,5 -12,4 7.56% | -10,8 -12,0 9.8% | -13,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -13,4 |
|
Net income Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -13,4 |
|
EPS USD | Released Forecast Spread | -232 -224 -3.37% | -23,0 -23,0 0% | -12,5 -13,3 6.31% | -10,1 -10,9 7.51% | -5,20 -6,26 16.93% | -3,56 |
| Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 12,5 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBIT Million USD | Released Forecast Spread | -3,45 -4,40 21.59% | -2,64 -4,10 35.61% | -2,52 -4,10 38.51% | -3,57 9,90 -136.07% | -2,73 -3,70 26.22% | -2,78 -2,80 0.86% | -1,90 -3,10 38.74% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,45 -4,40 21.57% | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 9,90 -136.12% | -2,73 -3,70 26.19% | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | |
|
Net income Million USD | Released Forecast Spread | -3,45 -4,40 21.57% | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 7,50 -147.68% | -2,73 -3,70 26.19% | -2,55 | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% |
|
EPS USD | Released Forecast Spread | -3,12 -3,84 18.75% | -2,28 -3,60 36.67% | -2,28 -3,72 38.71% | -3,12 4,32 -172.22% | -2,42 -3,24 25.31% | -1,47 | -1,14 -1,43 20.28% | -0,17 -1,30 86.92% |
| Announcement Date | 22/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | 01/04/24 |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
